Sign In
Buy OGN
$13.38
+0.0200 (+0.150%)
At Close: Jun 02, 2026
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Organon & Co. (OGN)
12:04pm, Tuesday, 02'nd Jun 2026
Bala Cynwyd, Pennsylvania--(Newsfile Corp. - June 2, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Organon & Co. ("Organon
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know
10:01am, Friday, 29'th May 2026
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Orogen Reports Strong Q1 2026 Results with 144% Growth in Net Income
07:30am, Tuesday, 26'th May 2026
VANCOUVER, BC / ACCESS Newswire / May 26, 2026 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to report record revenue and after-tax profit for the three-month
Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia
05:06am, Thursday, 21'st May 2026
Shin Hae-gon (right), Head of Overseas Sales at Hanmi Pharmaceutical, and Andreas Daugaard Jørgensen (left), Managing Director, Organon Asia Pacific Cluster, met at Organon's Malaysia office to discu
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
10:00am, Monday, 18'th May 2026
Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Organon to Present New Research on Access and Value at ISPOR 2026
08:00am, Friday, 15'th May 2026
Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, will present data acros
Organon to Present New Research on Access and Value at ISPOR 2026
07:30am, Friday, 15'th May 2026
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon to present 8 abstracts on affordability, access and adoption across women's health, biosimilar and general medicines portfolio at ISPOR 2026.
Orogen Royalties Appoints Mr. Chad Wells to the Board of Directors
08:00am, Wednesday, 06'th May 2026
VANCOUVER, BC / ACCESS Newswire / May 6, 2026 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce the appointment of Mr. Chad Wells to the Company's Boar
BALA CYNWYD, Pa. , May 05, 2026 (GLOBE NEWSWIRE) -- Brodsky and Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—OGN, MMTX, VRE, and ESQ
11:51am, Tuesday, 05'th May 2026
NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders a
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Monday, 04'th May 2026
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Organon (OGN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
11:01am, Thursday, 30'th Apr 2026
The headline numbers for Organon (OGN) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Organon (OGN) Q1 Earnings and Revenues Miss Estimates
10:30am, Thursday, 30'th Apr 2026
Organon (OGN) came out with quarterly earnings of $0.71 per share, missing the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $1.02 per share a year ago.
Organon Reports Results for the First Quarter Ended March 31, 2026
07:30am, Thursday, 30'th Apr 2026
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN) today announced its results for the first quarter ended March 31, 2026. First Quarter 2026 Revenue in $ millions Q1 2026 Q1 2025 VPY
Organon Cancels First Quarter Earnings Call
07:30am, Wednesday, 29'th Apr 2026
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that it has
